Sara Ekberg

11PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 23, 2022
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission.

Sara Ekberg, Michael Crowther, Sara Harrysson

|Aug 16, 2022
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation.

Sara Ekberg, Karin E Smedby, Alexandra Albertsson-Lindblad

|Apr 25, 2022
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.

Sara Harrysson, Sandra Eloranta, Sara Ekberg

|Aug 26, 2021
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial.

Karin Fjordén, Sara Ekberg, Nevzeta Kuric

|Jul 31, 2021
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.

Elsa Brånvall, Sara Ekberg, Sandra Eloranta

|May 18, 2021
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study.

S Ekberg, S Harrysson, T Jernberg

Pageof 2

Frequent Collaborators

7 joint publications

Sandra Eloranta

3 joint publications

Mats Jerkeman

3 joint publications

Tove Wästerlid

2 joint publications

Sara Harrysson